D. D. Giri

1.1k total citations
21 papers, 859 citations indexed

About

D. D. Giri is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, D. D. Giri has authored 21 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in D. D. Giri's work include Breast Cancer Treatment Studies (6 papers), Advanced Breast Cancer Therapies (3 papers) and Estrogen and related hormone effects (3 papers). D. D. Giri is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Advanced Breast Cancer Therapies (3 papers) and Estrogen and related hormone effects (3 papers). D. D. Giri collaborates with scholars based in United Kingdom, United States and India. D. D. Giri's co-authors include James Underwood, S. A. C. Dundas, J Lawry, Sarat Chandarlapaty, Neal Rosen, Maura N. Dickler, Chengcheng Yang, Maurizio Scaltriti, José Baselga and J. C. E. Underwood and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

D. D. Giri

19 papers receiving 841 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. D. Giri United Kingdom 11 365 334 310 237 127 21 859
Sheila N.J. Sait United States 20 334 0.9× 510 1.5× 127 0.4× 192 0.8× 181 1.4× 72 1.2k
Josette Derré France 20 249 0.7× 662 2.0× 440 1.4× 154 0.6× 217 1.7× 47 1.4k
Purificación García‐Miguel Spain 18 292 0.8× 424 1.3× 181 0.6× 188 0.8× 65 0.5× 36 936
Mikael Behrendtz Sweden 22 271 0.7× 679 2.0× 176 0.6× 183 0.8× 158 1.2× 40 1.6k
Henrik Lilljebjörn Sweden 22 338 0.9× 588 1.8× 251 0.8× 264 1.1× 116 0.9× 51 1.6k
Jan Åkervall Sweden 20 418 1.1× 564 1.7× 164 0.5× 224 0.9× 216 1.7× 44 1.1k
L.W. Chu United States 10 252 0.7× 357 1.1× 147 0.5× 349 1.5× 368 2.9× 14 944
Gaia Roversi Italy 13 131 0.4× 592 1.8× 139 0.4× 121 0.5× 137 1.1× 18 960
Dominiek Smeets Belgium 13 308 0.8× 283 0.8× 155 0.5× 235 1.0× 87 0.7× 19 719
B Devictor France 18 260 0.7× 340 1.0× 76 0.2× 156 0.7× 62 0.5× 39 773

Countries citing papers authored by D. D. Giri

Since Specialization
Citations

This map shows the geographic impact of D. D. Giri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. D. Giri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. D. Giri more than expected).

Fields of papers citing papers by D. D. Giri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. D. Giri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. D. Giri. The network helps show where D. D. Giri may publish in the future.

Co-authorship network of co-authors of D. D. Giri

This figure shows the co-authorship network connecting the top 25 collaborators of D. D. Giri. A scholar is included among the top collaborators of D. D. Giri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. D. Giri. D. D. Giri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Giri, D. D., et al.. (2021). Trends and issues in community mental health programs in India. SHILAP Revista de lepidopterología. 30(1). 11–17. 4 indexed citations
3.
Grisham, Rachel N., D. D. Giri, Alexia Iasonos, et al.. (2019). 38 Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: final results. A23.1–A23. 2 indexed citations
4.
Gucalp, Ayca, Neil M. Iyengar, Xi Kathy Zhou, et al.. (2017). Periprostatic adipose inflammation is associated with high-grade prostate cancer. Prostate Cancer and Prostatic Diseases. 20(4). 418–423. 62 indexed citations
5.
Yang, Chengcheng, Maura N. Dickler, D. D. Giri, et al.. (2016). Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence. Oncogene. 36(16). 2255–2264. 283 indexed citations
6.
Walsh, Logan A., David M. Roy, Marsha Reyngold, et al.. (2014). RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch. Oncogene. 34(17). 2189–2203. 32 indexed citations
7.
8.
Chandarlapaty, Sarat, Carla De Giovanni, D. D. Giri, et al.. (2012). Abstract PD04-05: Molecular predictors for type of recurrence following conservative treatment for DCIS. Cancer Research. 72(24_Supplement). PD04–5. 1 indexed citations
9.
Gucalp, Ayca, SM Tolaney, SJ Isakoff, et al.. (2011). TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR- metastatic breast cancer (MBC).. Journal of Clinical Oncology. 29(15_suppl). TPS122–TPS122. 4 indexed citations
10.
Khan, Raja B., D. D. Giri, Marc K. Rosenblum, Frank Petito, & Lisa M. DeAngelis. (2001). Leptomeningeal metastasis from an intracranial epidermoid cyst. Neurology. 56(10). 1419–1420. 17 indexed citations
11.
Hoda, Syed A., Manju L. Prasad, A. Moore, Rana S. Hoda, & D. D. Giri. (2000). Author's reply. Histopathology. 37(5). 478–478. 6 indexed citations
12.
Bhatavdekar, Jyotsna M., et al.. (1992). Endocrine function in premenopausal and postmenopausal advanced breast cancer patients treated with CMF or tamoxifen.. PubMed. 39(2). 123–7. 5 indexed citations
13.
Lawry, J, D. D. Giri, K Rogers, & J L Duncan. (1990). The value of assessing cell proliferation in breast cancer. Journal of Microscopy. 159(3). 265–275. 11 indexed citations
14.
Giri, D. D., et al.. (1989). Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological study. Histopathology. 15(6). 575–584. 62 indexed citations
15.
16.
Stephenson, Timothy J., et al.. (1989). Pseudomembranous trigonitis of the bladder: hormonal aetiology.. Journal of Clinical Pathology. 42(9). 922–926. 20 indexed citations
17.
Giri, D. D., J R Goepel, Kenita S. Rogers, & J. C. E. Underwood. (1988). Immunohistological demonstration of progesterone receptor in breast carcinomas: correlation with radioligand binding assays and oestrogen receptor immunohistology.. Journal of Clinical Pathology. 41(4). 444–447. 29 indexed citations
18.
Underwood, James & D. D. Giri. (1988). Nucleolar organizer regions as diagnostic discriminants for malignancy. The Journal of Pathology. 155(2). 95–96. 125 indexed citations
19.
20.
Giri, D. D., et al.. (1987). Clinicopathological significance of intratumoural variations in elastosis grades and the oestrogen receptor status of human breast carcinomas. The Journal of Pathology. 151(4). 297–303. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheila N.J. Sait Breakdown of academic impact, for papers by Josette Derré Breakdown of academic impact, for papers by Purificación García‐Miguel Breakdown of academic impact, for papers by Mikael Behrendtz Breakdown of academic impact, for papers by Henrik Lilljebjörn Breakdown of academic impact, for papers by Jan Åkervall Breakdown of academic impact, for papers by L.W. Chu Breakdown of academic impact, for papers by Gaia Roversi Breakdown of academic impact, for papers by Dominiek Smeets Breakdown of academic impact, for papers by B Devictor
Rankless by CCL
2026